256 related articles for article (PubMed ID: 27717335)
21. Outcomes in nasopharyngeal carcinoma: Results from a nonendemic cohort.
Laskar SG; Gurram L; Gupta T; Budrukkar A; Murthy V; Agarwal JP
Indian J Cancer; 2016; 53(4):493-498. PubMed ID: 28485337
[TBL] [Abstract][Full Text] [Related]
22. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
Zhang B; Hu Y; Xiong RH; Pan YF; Xu QL; Kong XY; Cai R; Chen QQ; Tang HY; Jiang W
Oncotarget; 2017 Feb; 8(8):14078-14088. PubMed ID: 27845907
[TBL] [Abstract][Full Text] [Related]
23. The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy.
Tian YM; Huang WZ; Yuan X; Bai L; Zhao C; Han F
Oncotarget; 2017 Jun; 8(26):43450-43457. PubMed ID: 28427216
[TBL] [Abstract][Full Text] [Related]
24. Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma.
Liu YC; Wang WY; Twu CW; Jiang RS; Liang KL; Lin PJ; Lin JW; Lin JC
Sci Rep; 2018 Jan; 8(1):470. PubMed ID: 29323141
[TBL] [Abstract][Full Text] [Related]
25. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
[TBL] [Abstract][Full Text] [Related]
26. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area.
Boustani J; Ruffier A; Moya-Plana A; Tao Y; Nguyen F; Even C; Berthold C; Casiraghi O; Temam S; Blanchard P
Strahlenther Onkol; 2021 Mar; 197(3):188-197. PubMed ID: 32514613
[TBL] [Abstract][Full Text] [Related]
28. Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions.
Wang SY; Lou JL; Chen J; Zhang SZ; Guo L
World J Surg Oncol; 2016 Mar; 14():89. PubMed ID: 27012522
[TBL] [Abstract][Full Text] [Related]
29. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
31. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
Song JH; Wu HG; Keam BS; Hah JH; Ahn YC; Oh D; Noh JM; Park HJ; Lee CG; Keum KC; Cha J; Cho KH; Moon SH; Kim JY; Chung WK; Oh YT; Kim WT; Cho MJ; Kay CS; Kim YS
Cancer Res Treat; 2016 Jul; 48(3):917-27. PubMed ID: 26727716
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy.
Wang M; Xu Y; Chen X; Chen H; Gong H; Chen S
J Cancer Res Ther; 2016; 12(2):909-14. PubMed ID: 27461673
[TBL] [Abstract][Full Text] [Related]
33. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
[TBL] [Abstract][Full Text] [Related]
34. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
[TBL] [Abstract][Full Text] [Related]
35. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
[TBL] [Abstract][Full Text] [Related]
36. A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes.
Xu T; Zhu G; He X; Ying H; Hu C
Oral Oncol; 2014 Feb; 50(2):71-6. PubMed ID: 24315404
[TBL] [Abstract][Full Text] [Related]
37. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
38. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
[TBL] [Abstract][Full Text] [Related]
39. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors.
Vlantis AC; Chan HS; Tong MC; Yu BK; Kam MK; van Hasselt CA
Head Neck; 2011 Aug; 33(8):1126-31. PubMed ID: 21755557
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]